2016 DUPONT DATA BOOK - s2.q4cdn.com · DuPont Data Book 1 DuPont Investor Relations The DuPont DATA BOOK has been prepared to assist financial analysts, ... (iii) the ability of

2016 DUPONT DATA BOOK

1 DuPont Investor Relations

2 Corporate Financial Data

Consolidated Income Statements

Consolidated Balance Sheets

Consolidated Statements of Cash Flows

Segment Information

Selected Additional Data

10 Innovation

12 Business Segments

Agriculture

Electronics & Communications

Industrial Biosciences

Nutrition & Health

Performance Materials

Protection Solutions

18 Board of Directors and

DuPont Senior Leadership

Individual Shareholder Relations:

(302) 774-3034

Main Office Number:

(302) 774-4994

Internet: www.dupont.com

Contents

DuPont Data Book 1

DuPont Investor Relations

The DuPont DATA BOOK has been prepared to assist financial analysts, portfolio managers and others in understanding and evaluating the company. This book presents graphics, tabular and other statistical data about the consolidated company and its business segments.

Forward-Looking StatementsThis DATA BOOK contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” “will,” “would,” “target,” similar expressions, and variations or negatives of these words.

Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the consummation of the proposed transaction and the anticipated benefits thereof. Forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events which may not be realized. Forward-looking statements also involve risks and uncertainties, many of which are beyond the company’s control. Some of the important factors that could cause the company’s actual results to differ materially from those projected in any such forward-looking statements are: fluctuations in energy and raw material prices; failure to develop and market new products and optimally manage product life cycles; ability to respond to market acceptance, rules, regulations and policies affecting products based on biotechnology and, in general, for products for the agriculture industry; outcome of significant litigation and environmental matters, including realization of associated indemnification assets, if any; failure to appropriately manage process safety and product stewardship issues; changes in laws and regulations or political conditions; global economic and capital markets conditions, such as inflation, interest and currency exchange rates; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, natural disasters and weather events and patterns which could affect demand as well as availability of products for the agriculture industry; ability to protect and enforce the company’s intellectual property rights; successful integration of acquired businesses and separation of underperforming or non-strategic assets or businesses; and risks related to the agreement entered on December 11, 2015, with The Dow Chemical Company pursuant to which the companies have agreed to effect an all-stock merger of equals, including the completion of the proposed transaction on anticipated terms and timing, the ability to fully and timely realize the expected benefits of the proposed transaction and risks related to the intended business separations contemplated to occur after the completion of the proposed transaction. Important risk factors relating to the proposed transaction and intended business separations include, but are not limited to, (i) the completion of the proposed transaction on anticipated terms and timing, including obtaining regulatory approvals, anticipated tax treatment, unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, synergies, economic performance, indebtedness, financial condition, losses, future prospects, business and management strategies for the management, expansion and growth of the new combined company’s operations and other conditions to the completion of the merger, (ii) the various approvals, authorizations and declarations of non-objection from certain regulatory and governmental authorities may not be obtained, on a timely basis or otherwise, including that these regulatory or governmental agencies may impose conditions on the granting of such approvals, including requiring the respective Dow and DuPont businesses to divest certain assets if necessary in order to obtain certain regulatory approvals or otherwise limiting the ability of the combined company to integrate

parts of the DuPont and Dow businesses, (iii) the ability of Dow and DuPont to integrate the business successfully and to achieve anticipated synergies, risks and costs and pursuit and/or implementation of the potential separations, including anticipated timing, any changes to the configuration of businesses included in the potential separation if implemented, (iv) the intended separation of the agriculture, material science and specialty products businesses of the combined company post-mergers in one or more tax efficient transactions on anticipated terms and timing, including a number of conditions which could delay, prevent or otherwise adversely affect the proposed transactions, including possible issues or delays in obtaining required regulatory approvals or clearances, disruptions in the financial markets or other potential barriers, (v) continued availability of capital and financing and rating agency actions, (vi) potential business uncertainty, including changes to existing business relationships, during the pendency of the merger that could affect DuPont’s financial performance, and (vii) certain restrictions during the pendency of the merger that may impact DuPont’s ability to pursue certain business opportunities or strategic transactions. These risks, as well as other risks associated with the proposed merger, are more fully discussed in the joint proxy statement of Dow and DuPont and the prospectus of DowDuPont included in the definitive registration statement on Form S-4 (File No. 333-209869), (as amended, the Registration Statement). While the list of factors presented here is, and the list of factors presented in the Registration Statement are, considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DuPont’s consolidated financial condition, results of operations, credit rating or liquidity. The company undertakes no duty to publicly revise or update any forward-looking statements whether as a result of future developments, new information or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

Use of Non-GAAP MeasuresAs a supplement to DuPont financial results prepared in accordance with U.S. generally accepted accounting principles (GAAP), this DATA BOOK presents non-GAAP measures. Consolidated company and segment results are shown on an operating earnings basis, which excludes significant items and non-operating pension and other postretirement employee benefit costs. Non-GAAP measures include but are not limited to operating earnings and operating earnings per share; operating earnings before interest, taxes, and noncontrolling interests (EBIT), as defined by the company; operating earnings before interest, taxes, noncontrolling interests, depreciation and amortization (EBITDA); and free cash flow. Non-GAAP measures are not a substitute for GAAP results. The company uses non-GAAP measures to evaluate and manage the company’s operations. The company believes that a discussion of operating results provides a useful analysis of ongoing operations. The determination of significant items may not be comparable to similarly titled measures used by other companies. This data should be read in conjunction with previously published company reports on Forms 10-K, 10-Q, and 8-K. These reports, along with reconciliations on non-GAAP measures to GAAP are available on the Investor Center of www.dupont.com.

For complete details of significant items, see DuPont quarterly earnings news releases.

The DuPont DATA BOOK is available at www.dupont.com.

March 2017

Lori KochDirector

(302) 999-5631

Pat EshamSpecialist

(302) 999-5513

Greg FriedmanVice President (302) 999-5504

Jennifer DriscollDirector

(302) 999-5510

Ann GiancristoforoManager

(302) 999-5511

DuPont Investor Relations

The DuPont DATA BOOK has been prepared to assist financial analysts, portfolio managers and others in understanding and evaluating the company. This book presents graphics, tabular and other statistical data about the consolidated company and its business segments.

Forward-Looking StatementsThis DATA BOOK contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” “will,” “would,” “target,” similar expressions, and variations or negatives of these words.

Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the consummation of the proposed transaction and the anticipated benefits thereof. Forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events which may not be realized. Forward-looking statements also involve risks and uncertainties, many of which are beyond the company’s control. Some of the important factors that could cause the company’s actual results to differ materially from those projected in any such forward-looking statements are: fluctuations in energy and raw material prices; failure to develop and market new products and optimally manage product life cycles; ability to respond to market acceptance, rules, regulations and policies affecting products based on biotechnology and, in general, for products for the agriculture industry; outcome of significant litigation and environmental matters, including realization of associated indemnification assets, if any; failure to appropriately manage process safety and product stewardship issues; changes in laws and regulations or political conditions; global economic and capital markets conditions, such as inflation, interest and currency exchange rates; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, natural disasters and weather events and patterns which could affect demand as well as availability of products for the agriculture industry; ability to protect and enforce the company’s intellectual property rights; successful integration of acquired businesses and separation of underperforming or non-strategic assets or businesses; and risks related to the agreement entered on December 11, 2015, with The Dow Chemical Company pursuant to which the companies have agreed to effect an all-stock merger of equals, including the completion of the proposed transaction on anticipated terms and timing, the ability to fully and timely realize the expected benefits of the proposed transaction and risks related to the intended business separations contemplated to occur after the completion of the proposed transaction. Important risk factors relating to the proposed transaction and intended business separations include, but are not limited to, (i) the completion of the proposed transaction on anticipated terms and timing, including obtaining regulatory approvals, anticipated tax treatment, unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, synergies, economic performance, indebtedness, financial condition, losses, future prospects, business and management strategies for the management, expansion and growth of the new combined company’s operations and other conditions to the completion of the merger, (ii) the various approvals, authorizations and declarations of non-objection from certain regulatory and governmental authorities may not be obtained, on a timely basis or otherwise, including that these regulatory or governmental agencies may impose conditions on the granting of such approvals, including requiring the respective Dow and DuPont businesses to divest certain assets if necessary in order to obtain certain regulatory approvals or otherwise limiting the ability of the combined company to integrate parts of the DuPont and Dow businesses, (iii) the ability of Dow and DuPont to integrate the business successfully and to achieve anticipated synergies, risks and costs and pursuit and/or implementation of the potential separations, including anticipated timing, any changes to the configuration of businesses included in the potential separation if implemented, (iv) the intended separation of the agriculture,

material science and specialty products businesses of the combined company post-mergers in one or more tax efficient transactions on anticipated terms and timing, including a number of conditions which could delay, prevent or otherwise adversely affect the proposed transactions, including possible issues or delays in obtaining required regulatory approvals or clearances, disruptions in the financial markets or other potential barriers, (v) continued availability of capital and financing and rating agency actions, (vi) potential business uncertainty, including changes to existing business relationships, during the pendency of the merger that could affect DuPont’s financial performance, and (vii) certain restrictions during the pendency of the merger that may impact DuPont’s ability to pursue certain business opportunities or strategic transactions. These risks, as well as other risks associated with the proposed merger, are more fully discussed in the joint proxy statement of Dow and DuPont and the prospectus of DowDuPont included in the definitive registration statement on Form S-4 (File No. 333-209869), (as amended, the Registration Statement). While the list of factors presented here is, and the list of factors presented in the Registration Statement are, considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on DuPont’s consolidated financial condition, results of operations, credit rating or liquidity. The company undertakes no duty to publicly revise or update any forward-looking statements whether as a result of future developments, new information or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.

Use of Non-GAAP MeasuresThis DATA BOOK includes information that does not conform to U.S. generally accepted accounting principles (GAAP) and are considered non-GAAP measures. These measures include the company’s consolidated results and earnings per share on an operating earnings basis, which excludes significant items and non-operating pension and other postretirement employee benefit costs (operating earnings and operating EPS). Management uses these measures internally for planning, forecasting and evaluating the performance of the Company’s segments, including allocating resources and evaluating incentive compensation. The non-GAAP measures also include operating earnings before interest, taxes and noncontrolling interests (Adjusted EBIT) and operating earnings before interest, taxes, noncontrolling interests, depreciation and amortization (Adjusted EBITDA). Management believes that these non-GAAP measurements are meaningful to investors as they provide insight with respect to ongoing operating results of the company and provide a more useful comparison of year-over-year results. From a liquidity perspective, management uses free cash flow which is defined as cash provided/used by operating activities less purchases of property, plant and equipment. Free cash flow is useful to investors and management to evaluate the company’s cash flow and financial performance, and is an integral financial measure used in the company’s financial planning process. These non-GAAP measurements supplement our GAAP disclosures and should not be viewed as an alternative to GAAP measures of performance. This data should be read in conjunction with previously published company reports on Forms 10-K, 10-Q, and 8-K. These reports, along with reconciliations of non-GAAP measures to GAAP are available on the Investor Center of www.dupont.com under Filings and Reports – Reconciliations and Other Data. Reconciliations of non-GAAP measures to GAAP are also included with this document.

The determination of significant items may not be comparable to similarly titled measures used by other companies. For complete details of significant items, see DuPont quarterly earnings news releases.

The DuPont DATA BOOK is available at www.dupont.com.March 2017

Lori KochDirector

(302) 999-5631

Pat EshamSpecialist

(302) 999-5513

Greg FriedmanVice President (302) 999-5504

Jennifer DriscollDirector

(302) 999-5510

Ann GiancristoforoManager

(302) 999-5511

http://www.dupont.com

http://www.dupont.com

DuPont Data Book 2

Corporate Financial DataCorporate Highlights (dollars in millions, except per share) 2012 2013 2014 2015 2016Operating Results1

Net sales $ 27,610 $ 28,998 $ 28,406 $ 25,130 $ 24,594 Income from continuing operations after income taxes 1,168 2,206 3,145 1,895 2,521 Operating earnings after income taxes2 2,238 2,926 3,110 2,503 2,951 Depreciation 1,065 1,027 1,006 978 939 Adjusted EBIT2 3,311 4,019 4,599 3,757 4,182 Adjusted EBITDA2 4,680 5,360 5,965 5,095 5,440 Cash provided by operating activities3 4,939 3,266 3,810 2,422 3,357 Purchases of property, plant and equipment 1,793 1,882 2,020 1,629 1,019 Research and development expense 2,001 2,037 1,958 1,898 1,641

Financial Position, Year EndTotal assets 50,339 52,142 50,490 41,166 39,964 Working capital1 6,866 10,055 8,220 7,071 8,220 Total debt 11,704 12,420 10,655 8,807 8,536 DuPont stockholders’ equity 10,208 16,229 13,320 9,993 9,998

Data Per Common ShareIncome from continuing operations after income taxes – diluted 1.20 2.34 3.39 2.09 2.85 Operating earnings after income taxes – diluted 2.36 3.12 3.36 2.77 3.35 Dividends 1.70 1.78 1.84 1.72 1.52 Market price Year-end close 44.98 64.97 73.94 66.60 73.40 High-low range 53.98–41.67 65.00–45.11 75.82–59.35 80.65–47.11 75.86–50.71Book value at year-end 10.69 17.25 14.46 11.20 11.31 Average number of shares (millions) – diluted 942 933 922 900 877Shares outstanding – year-end (millions) 933 927 905 871 863

RatiosTotal stockholder return 1.8% 49.2% 17.0% -2.7% 12.8% Dividend yield 3.8% 2.7% 2.5% 2.6% 2.1% Share price increase (decrease) -1.7% 44.4% 13.8% -9.9% 10.2%P/E on operating earnings2 after income taxes 19 21 22 24 22 Dividend payout, as percentage of operating earnings2 per share 72.0% 57.1% 54.8% 62.1% 45.4%Return on average investors’ capital (operating earnings2) 10.5% 12.1% 12.1% 11.9% 15.9%Asset turnover ratio1 61.5% 62.5% 64.2% 61.0% 61.5%Debt to total capital 53.2% 43.3% 44.3% 46.3% 45.6%Interest coverage ratio (operating earnings2) 7.1 9.0 11.7 10.7 12.0Current ratio1 1.6 1.8 1.7 1.7 1.9Exchange loss (operating earnings2) – net of tax (136) (66) (166) (127) (122)

Employees4

Number of employees – year-end (thousands) 61 55 54 52 46

Stockholder Return DuPont* S&P 500* Proxy Peers**

One Year 13% 12% 15% Three Year 28% 29% 24% Five Year 95% 98% 85%

Total Stockholder Return through December 31, 2016

* Source: Thomson Reuters Datastream as of 12/31/2016. Total shareholder return (TSR) is calculated as the appreciation or depreciation of a particular share, plus any dividends, over a given period, expressed as a percentage of the share’s value at the beginning of the period. Closing prices are adjusted for spin-offs, stock splits, rights and special dividends.

** 2016 Proxy Peers: 3M, Baxter, Caterpillar, Danaher, Deere & Company, Dow Chemical, Emerson Electric, Honeywell, Ingersoll-Rand, Johnson & Johnson, Johnson Controls, Kimberly-Clark, Merck, Monsanto, Procter & Gamble, Syngenta, and United Technologies. TSR reported on a market cap-weighted basis.

Cash Returned to Shareholders

2015 2016

(dol

lars

in m

illio

ns)

$4,000

$1,000

$2,000

$3,000

$0201420132012

Share Repurchase Dividends

1 On July 1, 2015, the company completed the spin-off of its Performance Chemicals segment. Accordingly, the results of Performance Chemicals are presented as discontinued operations and as such have been excluded from continuing operations, operating earnings, segment results and calculations for all periods presented.

2 See page 9 for reconciliations of non-GAAP measures.3 Reflects the January 1, 2017, retrospective adoption of ASU 2016-09, Compensation – Stock Compensation (Topic 718), Improvements to Employee Share-Based Payment Accounting.4 Number of employees excludes employees associated with the Performance Chemicals segment for all years presented.

DuPont Data Book 3

2012 2013 2014 2015 2016Operating Results1

Net sales $ 27,610 $ 28,998 $ 28,406 $ 25,130 $ 24,594 Income from continuing operations after income taxes 1,168 2,206 3,145 1,895 2,521 Operating earnings after income taxes2 2,238 2,926 3,110 2,503 2,951 Depreciation 1,065 1,027 1,006 978 939 Adjusted EBIT2 3,311 4,019 4,599 3,757 4,182 Adjusted EBITDA2 4,680 5,360 5,965 5,095 5,440 Cash provided by operating activities3 4,939 3,266 3,810 2,422 3,357 Purchases of property, plant and equipment 1,793 1,882 2,020 1,629 1,019 Research and development expense 2,001 2,037 1,958 1,898 1,641

Financial Position, Year EndTotal assets 50,339 52,142 50,490 41,166 39,964 Working capital1 6,866 10,055 8,220 7,071 8,220 Total debt 11,704 12,420 10,655 8,807 8,536 DuPont stockholders’ equity 10,208 16,229 13,320 9,993 9,998

Data Per Common ShareIncome from continuing operations after income taxes – diluted 1.20 2.34 3.39 2.09 2.85 Operating earnings after income taxes – diluted 2.36 3.12 3.36 2.77 3.35 Dividends 1.70 1.78 1.84 1.72 1.52 Market price Year-end close 44.98 64.97 73.94 66.60 73.40 High-low range 53.98–41.67 65.00–45.11 75.82–59.35 80.65–47.11 75.86–50.71Book value at year-end 10.69 17.25 14.46 11.20 11.31 Average number of shares (millions) – diluted 942 933 922 900 877Shares outstanding – year-end (millions) 933 927 905 871 863

RatiosTotal stockholder return 1.8% 49.2% 17.0% -2.7% 12.8% Dividend yield 3.8% 2.7% 2.5% 2.6% 2.1% Share price increase (decrease) -1.7% 44.4% 13.8% -9.9% 10.2%P/E on operating earnings2 after income taxes 19 21 22 24 22 Dividend payout, as percentage of operating earnings2 per share 72.0% 57.1% 54.8% 62.1% 45.4%Return on average investors’ capital (operating earnings2) 10.5% 12.1% 12.1% 11.9% 15.9%Asset turnover ratio1 61.5% 62.5% 64.2% 61.0% 61.5%Debt to total capital 53.2% 43.3% 44.3% 46.3% 45.6%Interest coverage ratio (operating earnings2) 7.1 9.0 11.7 10.7 12.0Current ratio1 1.6 1.8 1.7 1.7 1.9Exchange loss (operating earnings2) – net of tax (136) (66) (166) (127) (122)

Employees4

Number of employees – year-end (thousands) 61 55 54 52 46

Consolidated Income Statements (dollars in millions, except per share)

For the year ended December 31, 2012 2013 2014 2015 2016

Net sales $ 27,610 $ 28,998 $ 28,406 $ 25,130 $ 24,594 Cost of goods sold 16,862 17,642 17,023 15,112 14,469

Other operating charges 1,555 1,222 645 459 686

Selling, general and administrative expenses 5,413 5,342 4,891 4,615 4,319

Research and development expense 2,001 2,037 1,958 1,898 1,641

Other income, net* (432) (371) (1,277) (697) (708)

Interest expense 464 448 377 342 370

Employee separation/asset related charges, net 457 112 476 810 552

Income from continuing operations before income taxes 1,290 2,566 4,313 2,591 3,265

Provision for income taxes on continuing operations 122 360 1,168 696 744

Income from continuing operations after income taxes 1,168 2,206 3,145 1,895 2,521

Income from discontinued operations after income taxes 1,612 2,656 491 64 4

Net income 2,780 4,862 3,636 1,959 2,525

Less: Net income attributable to noncontrolling interests 25 14 11 6 12

Net income attributable to DuPont 2,755 4,848 3,625 1,953 2,513

Diluted earnings per share of common stock from continuing operations 1.20 2.34 3.39 2.09 2.85

*Other income, net Royalty income 152 163 156 138 170 Interest income 109 136 129 129 107 Equity in earnings (loss) of affiliates, net 74 22 (36) 49 99 Gain on sale of equity method investment 122 9 — — — Net gains on sales of businesses and other assets 129 21 710 92 435 Net exchange gains (losses) (212) (101) 196 30 (106) Cozaar®/Hyzaar® income 54 14 — — — Miscellaneous income and expenses, net 4 107 122 259 3 Total other income, net 432 371 1,277 697 708

Financial Results by Quarter 2014 2015 2016Net sales

1st $ 8,594 $ 7,837 $ 7,405 2nd 8,058 7,121 7,061 3rd 5,905 4,873 4,917 4th 5,849 5,299 5,211

Total 28,406 25,130 24,594

Operating earnings after income taxes 1

1st 1,323 1,153 1,109 2nd 907 994 1,093 3rd 361 117 298 4th 519 239 451

Total 3,110 2,503 2,951

Operating earnings per share of common stock – diluted 1,2 1st 1.42 1.26 1.26 2nd 0.98 1.09 1.24 3rd 0.39 0.13 0.34 4th 0.57 0.27 0.51

Total 3.36 2.77 3.35

1 See page 9 for reconciliations of non-GAAP measures.2 Earnings per share for the year may not equal the sum of quarterly earnings per share due

to changes in average share calculations.

Selected Additional Data (dollars in millions, except per share)

Reconciliation of Base Income Tax Rate to Effective Income Tax RateBase income tax rate is defined as the effective income tax rate less the effect of exchange gains (losses), significant items and non-operating pension/OPEBs.

(dollars in millions) 2014 2015 2016Income from continuing operations before income taxes (GAAP) $ 4,313 $ 2,591 $ 3,265 Add: Significant items – charge (benefit) included in income1 (209) 453 519 Non-operating pension/OPEBs 128 397 40 Less: Net exchange gains (losses) 254 93 (106)Income from continuing operations before income taxes, significant items, exchange gains (losses), and non-operating pension/OPEBs 3,978 3,348 3,930

Provision for income taxes on continuing operations (GAAP) 1,168 696 744 Add: Tax benefits (expense) on significant items (97) 105 98 Tax benefits (expense) on non-operating pension/ OPEBs 41 131 19 Tax benefits (expense) on exchange gains (losses) (420) (220) (16)Provision for income taxes on operating earnings, excluding exchange gains (losses) 692 712 845

Effective income tax rate (GAAP) 27.1% 26.9% 22.8%Significant items effect and non-operating pension/ OPEBs effect (0.8%) 0.2% (0.3%)Tax rate, from continuing operations, before significant items and non-operating pension/OPEBs 26.3% 27.1% 22.5%Exchange gains (losses) effect (8.9%) (5.8%) (1.0%)Base income tax rate from continuing operations 17.4% 21.3% 21.5%1 See page 7 for detail of significant items.

DuPont Data Book 4

Corporate Financial DataConsolidated Balance Sheets (dollars in millions)December 31, 2012 2013 2014 2015 2016

AssetsCurrent assets Cash and cash equivalents $ 4,284 $ 8,941 $ 6,910 $ 5,300 $ 4,605 Marketable securities 123 145 124 906 1,362 Accounts and notes receivable, net 4,682 5,370 5,238 4,643 4,971 Inventories 6,591 6,994 6,787 6,140 5,673 Prepaid expenses 357 356 452 398 506 Assets held for sale 3,076 228 — — — Assets of discontinued operations 5,478 5,712 6,227 — — Total current assets 24,591 27,746 25,738 17,387 17,117

Property, plant and equipment 23,078 23,345 23,773 24,130 23,967 Less: Accumulated depreciation 13,214 13,400 13,765 14,346 14,736 Net property, plant and equipment 9,864 9,945 10,008 9,784 9,231 Goodwill 4,418 4,515 4,332 4,248 4,180 Other intangible assets 5,097 5,079 4,569 4,144 3,664 Investment in affiliates 1,033 891 762 688 649 Deferred income taxes 4,323 2,976 4,078 3,799 3,308 Other assets 1,013 990 1,003 1,116 1,815 Total 50,339 52,142 50,490 41,166 39,964

Liabilities and Stockholders EquityCurrent liabilities Accounts payable $ 3,926 $ 4,119 $ 3,786 $ 3,398 $ 3,705 Short-term borrowings and capital lease obligations 1,275 1,721 1,422 1,165 429 Income taxes 226 180 487 173 101 Other accrued liabilities 5,736 5,959 5,596 5,580 4,662 Liabilities related to assets held for sale 1,084 — — — — Liabilities of discontinued operations 2,440 2,596 2,467 — — Total current liabilities 14,687 14,575 13,758 10,316 8,897

Long-term borrowings and capital lease obligations 10,429 10,699 9,233 7,642 8,107 Other liabilities 14,333 9,910 13,615 12,591 12,333 Deferred income taxes 591 672 506 417 431 Total liabilities 40,040 35,856 37,112 30,966 29,768

Total DuPont stockholders’ equity 10,208 16,229 13,320 9,993 9,998 Noncontrolling interests 91 57 58 207 198 Total equity 10,299 16,286 13,378 10,200 10,196 Total 50,339 52,142 50,490 41,166 39,964

DuPont Data Book 5

Consolidated Statements of Cash Flows (dollars in millions)For the year ended December 31, 2012 2013 2014 2015 2016Operating activities Net income $ 2,780 $ 4,862 $ 3,636 $ 1,959 $ 2,525 Adjustments to reconcile net income to cash provided by operating activities: Depreciation 1,376 1,280 1,254 1,104 939 Amortization of intangible assets 337 323 363 362 319 Net periodic pension benefit cost 832 953 406 591 572 Contributions to pension plans (848) (313) (311) (308) (535) Gain on sales of businesses — (2,687) (726) (59) (436) Asset related charges 344 129 174 147 682 Other operating activites, net 18 41 192 106 366 Decrease (increase) in operating assets: Accounts and notes receivable 144 (976) (88) (448) (270) Inventories and other operating assets (843) (519) (318) 164 (54) Increase (decrease) in operating liabilities: Accounts payable and other operating liabilities1 1,065 267 (1,038) (1,031) (674) Accrued interest and income taxes1 (266) (94) 266 (165) (77)Cash provided by operating activities 4,939 3,266 3,810 2,422 3,357 Investing activities Purchases of property, plant and equipment (1,793) (1,882) (2,020) (1,629) (1,019) Investments in affiliates (97) (58) (42) (76) (19) Payments for businesses, net of cash acquired (18) (133) — (152) — Proceeds from sales of businesses and other assets, net 302 4,983 1,092 156 316 Purchases of short-term financial instruments (650) (497) (936) (1,897) (2,633) Proceeds from maturities and sales of short-term financial instruments 965 452 950 1,121 2,181 Foreign currency exchange contract settlements (40) 40 430 615 (385) Other investing activities, net (15) 40 189 34 45 Cash provided by (used for) investing activities (1,346) 2,945 (337) (1,828) (1,514)Financing activities Dividends paid to stockholders (1,594) (1,661) (1,696) (1,546) (1,335) Net increase (decrease) in short-term (less than 90 days) borrowings (200) 16 (11) (1) 387 Long-term and other borrowings: Receipts 323 2,013 104 3,679 813 Payments (916) (1,312) (1,794) (1,537) (1,440) Repurchase of common stock (400) (1,000) (2,000) (2,353) (916) Proceeds from exercise of stock options1 496 476 255 200 154 Payments for noncontrolling interest (470) (65) — — — Cash transferred to Chemours at spin-off — — — (250) — Other financing activities, net1 (26) (28) (30) (121) (48)Cash used for financing activities (2,787) (1,561) (5,172) (1,929) (2,385)Effect of exchange rate changes on cash (13) (88) (332) (275) (153)Cash classified as held for sale (95) — — — — Increase (decrease) in cash and cash equivalents 698 4,562 (2,031) (1,610) (695)Cash and cash equivalents at beginning of year 3,586 4,379 8,941 6,910 5,300 Cash and cash equivalents at end of year 4,284 8,941 6,910 5,300 4,605 Supplemental cash flow information:Cash paid during the year for Interest, net of amounts capitalized 501 489 394 341 386 Income taxes 1,054 1,323 1,016 885 735

2012–2016 Cash Waterfall

Cash fromOperations

Acquisitions Sale ofBusinesses

& Other Assets

PPE & Investmentin Affiliates

Dividends StockRepurchase

Net Change in

Borrowings

Cash 12/31/16

OtherCash12/31/11

$30

25

20

15

10

5

0

(dol

lars

in b

illio

ns)

Free Cash Flow*

*Free cash flow is defined as cash provided by operating activities less purchases of property, plant and equipment.

2014

(dol

lars

in m

illio

ns)

2013

$4,000

$3,000

$2,000

$1,000

$0201620152012

1 Reflects the January 1, 2017, retrospective adoption of ASU 2016-09, Compensation – Stock Compensation (Topic 718), Improvements to Employee Share-Based Payment Accounting.

DuPont Data Book 6

Corporate Financial Data2012 2013 2014 2015 2016

Segment Net Sales

Agriculture $ 10,421 $ 11,728 $ 11,296 $ 9,798 $ 9,516 Electronics & Communications 2,684 2,534 2,381 2,070 1,960 Industrial Biosciences 1,604 1,631 1,624 1,478 1,500 Nutrition & Health 3,422 3,473 3,529 3,256 3,268 Performance Materials 6,095 6,166 6,059 5,305 5,249 Protection Solutions 3,122 3,229 3,304 3,039 2,954 Other 262 237 213 184 147 Total segment net sales 27,610 28,998 28,406 25,130 24,594

Segment Pre-tax Operating EarningsAgriculture 2,129 2,480 2,352 1,646 1,758 Electronics & Communications 237 314 336 359 358 Industrial Biosciences 228 232 269 243 270 Nutrition & Health 305 286 369 373 504 Performance Materials 1,140 1,249 1,267 1,216 1,297 Protection Solutions 475 553 672 641 668 Other (125) (208) (233) (235) (215) Total segment pre-tax operating earnings 4,389 4,906 5,032 4,243 4,640 Exchange gains (losses) (212) (101) 254 93 (106)Corporate expenses (842) (773) (677) (573) (340)Interest expense (464) (448) (377) (322) (370)Operating earnings before income taxes 2,871 3,584 4,232 3,441 3,824 Non-operating pension and OPEBs (651) (533) (128) (397) (40)Net impact of significant items1 (930) (485) 209 (453) (519) Income from continuing operations before income taxes and noncontrolling interests 1,290 2,566 4,313 2,591 3,265

1 For complete details of significant items, see DuPont’s quarterly earnings news releases.

Segment Information (dollars in millions)

DuPont Data Book 7

Segment Information (dollars in millions)

2015 2016

1st 2nd 3rd 4th Full Yr. 1st 2nd 3rd 4th Full Yr.Segment Net Sales

Agriculture $ 3,937 $ 3,218 $ 1,093 $ 1,550 $ 9,798 $ 3,786 $ 3,218 $ 1,119 $ 1,393 $ 9,516 Electronics & Communications 517 528 532 493 2,070 452 494 493 521 1,960 Industrial Biosciences 350 357 374 397 1,478 352 355 392 401 1,500 Nutrition & Health 813 826 810 807 3,256 801 835 823 809 3,268 Performance Materials 1,381 1,338 1,302 1,284 5,305 1,249 1,335 1,334 1,331 5,249 Protection Solutions 790 806 723 720 3,039 729 786 722 717 2,954 Other 49 48 39 48 184 36 38 34 39 147 Total segment net sales 7,837 7,121 4,873 5,299 25,130 7,405 7,061 4,917 5,211 24,594

Segment Pre-tax Operating Earnings Agriculture 1,138 772 (210) (54) 1,646 1,101 865 (189) (19) 1,758 Electronics & Communications 79 89 104 87 359 59 93 108 98 358 Industrial Biosciences 54 50 61 78 243 63 62 78 67 270 Nutrition & Health 86 100 102 85 373 104 130 135 135 504 Performance Materials 317 301 317 281 1,216 273 325 371 328 1,297 Protection Solutions 167 181 146 147 641 176 188 162 142 668 Other (31) (46) (87) (71) (235) (59) (50) (58) (48) (215)

Total segment pre-tax operating earnings 1,810 1,447 433 553 4,243 1,717 1,613 607 703 4,640 Exchange gains (losses)1 142 11 (36) (24) 93 (121) (15) (76) 106 (106)Corporate expenses (154) (148) (111) (160) (573) (86) (83) (83) (88) (340)Interest expense (84) (74) (82) (82) (322) (92) (93) (93) (92) (370) Operating earnings before income taxes 1,714 1,236 204 287 3,441 1,418 1,422 355 629 3,824 Non-operating pension and OPEBs1 (109) (87) (115) (86) (397) (74) (133) (114) 281 (40) Pre-tax income before significant items2 1,605 1,149 89 201 3,044 1,344 1,289 241 910 3,784

Pre-tax Impact of Significant Items2

Imprelis herbicide recovery/adjustment (claims) 35 — 147 130 312 23 30 — — 53 Litigation settlement — 112 — 33 145 — — — — —Separation transaction costs (12) (25) (9) — (46) — — — — —Merger related costs — — — (10) (10) (24) (76) (122) (164) (386)Ukraine devaluation (40) — — — (40) — — — — —Gain on sale of entity — — — — — 369 — — — 369 Restructuring charge/adjustments — (2) — (775) (777) (77) 90 (17) 42 38 Asset impairments (37) — — — (37) — — (158) (435) (593) Net impact of significant items (54) 85 138 (622) (453) 291 44 (297) (557) (519)Income (loss) before income taxes and noncontrolling interests 1,551 1,234 227 (421) 2,591 1,635 1,333 (56) 353 3,265

1 In the first-quarter 2015, the impact of an exchange loss on non-operating pension of $23 was excluded from Exchange gains (losses) and included in Non-operating pension and OPEBs above. 2 For complete details of significant items, see DuPont’s quarterly earnings news releases.

DuPont Data Book 8

Net Sales by RegionGeographic Information (dollars in millions)

2016 Sourcing and Logistics Spend – Cash Basis – approximately $8.8 B**Management estimate

Primary Uses 2016a. Agricultural Activities . . . . . Pioneer, Cropb. Nutrition & Health . . . . . . . . . N&Hc. Metals . . . . . . . . . . . . . . . . . . . E&Cd. Natural Gas . . . . . . . . . . . . . . PM, DPSe. HMD . . . . . . . . . . . . . . . . . . . . PMf. Electricity . . . . . . . . . . . . . . . . DPS, N&H, E&Cg. Adipic acid . . . . . . . . . . . . . . . PMh. HDPE . . . . . . . . . . . . . . . . . . . . DPSi. Ethane . . . . . . . . . . . . . . . . . . . PMj. Fiberglass . . . . . . . . . . . . . . . . PMk. Methacrylates/Acrylates . . PM, DPSl. PTA/DMT/PX . . . . . . . . . . . . . IB, DPS, PMm. LDPE/LLDPE . . . . . . . . . . . . . . PMn. Methanol . . . . . . . . . . . . . . . . PMo. PTMEG . . . . . . . . . . . . . . . . . . PM

a

b

c

d

e

fg

hijklmno

Top Purchased Energyand Raw Materials 53%

Packaging and Logistics 13%

Other Purchased Energyand Raw Materials 34%

Top 15 Purchased Energy and Raw Materials

2016 Sales by Major Industry (percentage of total company)

*Includes military and law enforcement, apparel, and other consumer goods

0 5 10 15 20 25 30 4035

Agriculture

Food and Nutrition

Motor Vehicle andTransportation

Electrical and Electronics

Commercial and ResidentialConstruction/Materials

Chemical/Petrochemical

Plastics and Other Packaging

Other*

Percentage of total company

Other Industrial

(dol

lars

in m

illio

ns)

$12,000

$10,000

$8,000

$6,000

$4,000

$2,000

$0

U.S. and Canada Developed EMEA1 Developing EMEA1* Developed Asia Developing Asia* Latin America*

20152014 2016

Developing Market Sales (dollars in millions)

2014 2015 2016Total Net Sales $28,406 $25,130 $24,594 Developing Markets Total Net Sales % of Total

$9,698

34%

$8,196

33%

$8,373

34%

% of total 40 43 42 17 16 15 9 8 8 9 8 9 13 14 15 12 11 11

Selected Additional Data

Net Sales Outside the United States as a Percentage of Sales

2014 2015 2016

Agriculture 54% 50% 51%

Electronics & Communications 82% 80% 79%

Industrial Biosciences 61% 60% 59%

Nutrition & Health 68% 66% 66%

Performance Materials 70% 69% 71%

Protection Solutions 59% 57% 56%

Total1 63% 60% 61%

* For a list of countries comprising “Developing Markets,” see the Company’s Investor Center web site.

1 Europe, Middle East, and Africa

1 Total includes net sales reported in Other.

DuPont Data Book 9

Selected Additional Data(dollars in millions, except per share)

Reconciliation of Non-GAAP Measures

Reconciliation of Quarterly Operating Earnings After Tax

2012 2013 2014 2015 2016

Full Year Full Year 1Q 2Q 3Q 4Q Full Year 1Q 2Q 3Q 4Q Full Year 1Q 2Q 3Q 4Q Full Year

Income (loss) from continuing operations after income taxes (GAAP) $ 1,168 $ 2,206 $ 1,305 $ 932 $ 331 $ 577 $ 3,145 $ 1,021 $ 974 $ 131 $ (231) $ 1,895 $ 1,229 $ 1,027 $ 13 $ 252 $ 2,521

Less: Net income (loss) attributable to noncontrolling interests attributable to DuPont 24 13 6 3 1 — 10 4 5 — (3) 6 6 4 4 (2) 12

Add: Significant items – after-tax charge/(benefit) 657 377 2 (44) 9 (79) (112) 57 (32) (88) 411 348 (160) (19) 216 384 421

Add: Non-operating pension and OPEBs – after-tax 437 356 22 22 22 21 87 79 57 74 56 266 46 89 73 (187) 21

Operating earnings – After income taxes (Non-GAAP) 2,238 2,926 1,323 907 361 519 3,110 1,153 994 117 239 2,503 1,109 1,093 298 451 2,951

Reconciliation of Quarterly Operating EPS (a)

2012 2013 2014 2015 2016

Full Year Full Year 1Q 2Q 3Q 4Q Full Year 1Q 2Q 3Q 4Q Full Year 1Q 2Q 3Q 4Q Full Year

EPS from continuing operations (GAAP) $ 1.20 $ 2.34 $ 1.39 $ 1.00 $ 0.36 $ 0.63 $ 3.39 $ 1.11 $ 1.06 $ 0.14 (0.26) $ 2.09 $ 1.39 $ 1.16 $ 0.01 $ 0.29 $ 2.85

Add: Significant items charge (benefit) 0.70 0.40 0.00 (0.05) 0.01 (0.09) (0.12) 0.06 (0.04) (0.10) 0.47 0.39 (0.18) (0.02) 0.25 0.44 0.48

Add: Non-operating pension and OPEBs 0.46 0.38 0.03 0.03 0.02 0.03 0.09 0.09 0.07 0.09 0.06 0.29 0.05 0.10 0.08 (0.22) 0.02

Operating EPS (Non-GAAP) 2.36 3.12 1.42 0.98 0.39 0.57 3.36 1.26 1.09 0.13 0.27 2.77 1.26 1.24 0.34 0.51 3.35

(a) Earnings per share for the year may not equal the sum of quarterly earnings per share due to changes in average share calculations.

Reconciliation of Adjusted EBIT/EBITDA

2012 2013 2014 2015 2016

Income from continuing operations after income taxes (GAAP) $ 1,168 $ 2,206 $ 3,145 $ 1,895 $ 2,521

Add: Provision for income taxes on continuing operations 122 360 1,168 696 744

Income from continuing operations before income taxes (GAAP) 1,290 2,566 4,313 2,591 3,265

Add: Significant items – pretax charge/(benefit) 930 485 (209) 453 519

Add: Non-operating pension and OPEB – pretax 651 533 128 397 40

Operating earnings before income taxes (Non-GAAP) 2,871 3,584 4,232 3,441 3,824

Less: Net income attributable to noncontrolling interests 24 13 10 6 12

Add: Interest expense 464 448 377 322 370

Adjusted EBIT (Non-GAAP) 3,311 4,019 4,599 3,757 4,182

Add: Depreciation and amortization 1,369 1,341 1,366 1,338 1,258

Adjusted EBITDA (Non-GAAP) 4,680 5,360 5,965 5,095 5,440

DuPont Data Book 10

DuPont Innovation

Doug MuzykaSenior Vice President and Chief Science & Technology Officer

2016 Innovation Metrics (dollars in millions)

Metric Full Year 2016New products commercialized 1,643Sales from new products* $7,878 % Sales from new products* 32%Total R&D expense 1,641R&D as % of sales 7%

* Sales from new products launched within past four years

investment domain is strategically aligned to address critical needs of the marketplace. Work processes are optimized for each domain to deliver critical value elements for our overall R&D portfolio and contribute towards speed and efficiency of execution. We manage each project through a disciplined stage-gate process and critically evaluate them from both a technical and a market-back perspective, and make appropriate adjustments to achieve or exceed our commercialization targets.

Intellectual property rights, including patents, plant variety protection, trade secrets, confidential information, trademarks, trade dress, and copyrights are important to the company’s business. We continue to fully utilize all available forms of intellectual property rights to protect our investment in R&D and to enhance the value of our business.

Inclusive Innovation in ActionWe strengthen our internal science and market capabilities through collaborations and partnerships, including thousands of active technology agreements and collaborations. We have a global network of ten Innovation Centers, which combined with our regional research and business locations, enable us to tap into the global innovation network of customers, governments, NGOs, universities, and other strategic partners to develop innovative new solutions for regional and global issues.

External RecognitionWe are proud of the external awards that recognize our success and the contributions of our employees to the advancement of science. For the sixth consecutive year, DuPont was named to the Clarivate Analytics’ Top 100 Global Innovators list. Additionally, DuPont moved up 19 points to number 18 on Boston Consulting Group’s list of “Most Innovative Companies.” DuPont Industrial Biosciences and Archer Daniels Midland Company were honored with the “Breakthrough Solution of the Year” Award from Platts Global Energy for platform technology to produce a revolutionary biobased monomer. DuPont was named “Green Supplier of the Year” by top automotive supplier Yazaki. These are in addition to the many accolades DuPont scientists and engineers received during the year.

Sales from New ProductsIn 2016, DuPont recorded about $7.9 billion in sales from new products and applications launched between 2013 and 2016. Examples include new DuPont™ Tyvek® Protec™ roofing underlayment, new DuPont™ Nomex® Nano and Nano® Flex fire-resistant stretchable nonwovens for fire service, DuPont™ Temprion™ new portfolio of thermal management materials, additional new DuPont™ Cyrel® FAST plate processing technology, new DuPont™ Zytel® reinforced nylon for high temperatures in automotives, new DuPont™ Axtra® PHY enzymes and new DuPont™ Enviva® PRO direct fed microbials for animal nutrition, new DuPont™ Optimash® enzymes as DuPont’s first entry into the biogas sector, new enzymes for detergent and household use, new cultures for premium cheeses, new DuPont™ HOWARU® premium probiotics formulations for kids’ chewable tablets and high-dose vitamins and minerals, expanded launches for DuPont™ Zorvec™ disease control, DuPont™ Pioneer® brand hybrids with Leptra® insect protection and new EncircaSM services for growers.

DuPont scientists and engineers bring innovative products, materials, and services to the global marketplace to enable better, healthier and safer lives for people everywhere. We connect world-class science, technology and engineering to a deep understanding of commercial value chains and market knowledge to deliver value-added solutions for customers. Together, this total system of DuPont innovation continuously renews our portfolio, delivers new product lines, and transforms markets to deliver results for our shareholders, while providing science-based solutions to address global challenges. These challenges include feeding the world, decreasing our dependence on fossil fuels, and protecting people and the environment.

DuPont science and engineering are critical enablers for growth of all of our business segments. They draw on our rich mix of deep scientific and engineering disciplines, expert knowledge and leadership, and extensive collaboration to address significant market opportunities to advance new technologies, and create valuable new outcomes for our customers.

DuPont’s rich mix of technical competencies fuels scientific understanding and leads to new product inventions and solutions. Our unparalleled engineering capabilities provide new tools, processes and training that improve research, enable effective and rapid production scale-up, and make our assets more productive. Our global network of R&D centers and Innovation Centers, combined with strong collaborations and partnerships with external customers, universities, governments and others, enables our vision.

All of our scientific innovation is business-driven and is optimized to meet the competitive environments of the businesses served in the near-, mid- and long-term. More than 90 percent of our R&D investment is at the business level. Each business in the company directs R&D activities that support its business objectives, and the company supports cross-business and cross-functional investment to incubate new science-intensive growth opportunities additive to the existing business portfolios. This strategy has positioned DuPont as a leader in key strategic focus areas.

Investment in R&D In 2016, DuPont invested $1.6 billion in R&D, which was about 7 percent of sales. Return on R&D investment permeates all aspects of the planning and execution of innovation programs. We make strategic choices based on the balance of risk, time and reward to better focus our innovation portfolio to win in the fast-changing marketplace. The first critical step in maximizing the return on R&D investment is to prioritize and balance our portfolio. At DuPont, each R&D

DuPont Data Book 11 DuPont Data Book 11

GLOBAL REACH AND INNOVATION

10 GLOBAL INNOVATION CENTERS

• J O H N S T O N , I O W A , U . S .

• T R O Y, M I C H I G A N , U . S .

• PA U L Í N I A , B R A Z I L

• M E Y R I N , S W I T Z E R L A N D

• M O S CO W, R U S S I A

• I S TA N B U L , T U R K E Y

• D E L H I , I N D I A

• H S I N C H U , TA I W A N

• N A G O YA , J A PA N

• S H A N G H A I , C H I N A

Another critical element of our growth strategy is to advance our penetration in rapidly growing developing markets. We have a global network of R&D centers with comprehensive laboratory facilities, including major R&D centers located in the U.S. in Wilmington, Delaware; Johnston, Iowa; Palo Alto, California, and outside the U.S. in Paulinia, Brazil; Hyderabad, India; Shanghai, China; Meyrin, Switzerland; and Brabrand, Denmark. These centers of technical excellence conduct R&D across multiple fields and facilitate collaboration with the diverse global talent of our partners in business, government,

academia, and local communities. In 2016, we delivered four percent volume growth in developing markets. Broad-based volume growth was primarily driven by increased demand in agricultural and automotive markets, as we successfully leveraged market positions and deep relationships with customers around the world.

DuPont Innovation Centers in the Americas, Europe and Asia expand our network to link our scientists and engineers with customers, academicians, start-up companies, public sector officials, and other strategic partners to collaborate with us to solve critical challenges in the areas of food, energy and protection. The result is a powerful connection between

DuPont experts and our customers, helping us to understand localized needs and rapidly collaborate to develop innovative solutions to meet our customers’ needs. In 2016, our global network of Innovation Centers hosted more than 2,000 engagements with our partners, developed over 500 new projects targeting critical customer needs, and delivered significant revenue for our shareholders.

In addition, we connected select customers and more than 500 scientists from around the world with one another to broaden and deepen our science and technology relationships and feed our innovation pipeline through our annual technology conference, DuPont TechCon.

DuPont Data Book 12

DuPont AgricultureDuPont Agriculture is a leading supplier of innovative products and services that help the world increase the quantity and sustainability of our food supply and by extending our global reach, building upon leading market positions around the world. We leverage our strengths in breeding, agronomy, biology, chemistry, biotechnology and analytics along with our knowledge of the food value chain. Our businesses provide a leading portfolio of products and services including; Pioneer® brand seeds such as corn, oilseeds and rice; DuPont™ brand insect and disease control portfolio products; high-value, low-use-rate weed control products; and an expanding portfolio of seed treatment solutions. We are improving grower productivity to address the increasing needs of a growing population.

2016 Sales Data

By Major Product Group

Corn seeds 47%

Other seeds 9%

Insecticides 13%

Herbicides 10%

Fungicides 7%

Soybean seeds 14%

By Major Industry

Seeds 70%

Chemicals 30%

By Region

Europe** 20%

North America* 54%

Asia Pacific 10%

Latin America 16%

*Includes U.S. and Canada**Includes Europe, Middle East and Africa

Key CapabilitiesPlant geneticsBiotechnologyBiologyChemistryAgronomyAdvanced crop modeling and analytics

Key Products & ServicesSeedsTraitsFungicidesHerbicidesInsecticidesSeed treatmentsEncircaSM Services

Core MarketsProduction agriculture

Timothy P. GlennPresidentDuPont Crop Protection

James C. Collins Executive Vice PresidentDuPont AgricultureDuPont Pioneer Operating EarningsGrowth Strategies

• Advancing research pipeline and commercializing new products and services

• Expanding global leadership position with rapid growth in developing markets

• Capturing value through advantaged routes-to-market

• Continuing gains from productivity improvement

2015

(dol

lars

in m

illio

ns)

2014

$2,500

$2,000

$1,500

$1,000

$500

$02016

Overview (dollars in millions)

2014 2015 2016Net sales 11,296 9,798 9,516Operating earnings 2,352 1,646 1,758Operating earnings margin 20.8% 16.8% 18.5%Research and development 1,104 1,040 942Depreciation and amortization 436 453 417Equity in earnings of affiliates 31 31 7Segment net assets 6,696 6,751 6,342Affiliate net assets 240 234 222Purchases of property, plant and equipment 407 334 345

Acquisitions and Joint Ventures (2014–2016)MapShots, LLC – completed acquisition of software development company as

part of services strategy (2015)Taxon Biosciences, Inc. – a leading microbiome discovery company, acquired to

build upon capabilities to discover and commercialize biological solutions for agriculture customers globally (2015)

Divestitures and Shutdowns (2014–2016)Alfalfa business assets – sold to S&W Seed Company (2014) Copper fungicides business assets – sold to Mitsui & Co. (2014)Esfenvalerate insecticide business assets – sold to Sumitomo Chemicals (2014)Land Management herbicides business assets – sold to Bayer (2014)Bromacil herbicide business assets – sold to AMVAC (2015)Hexazinone herbicide business assets – sold to Tessenderlo Kerley Inc (2015)

DuPont Data Book 13

DuPont Electronics & CommunicationsElectronics & Communications is a leading supplier of enabling materials and technologies for solar energy (photovoltaics), consumer electronics, flat panel displays, advanced printing and other industrial electronic applications worldwide. As a leading specialty materials supplier to the photovoltaic (PV) industry, DuPont offers the broadest portfolio of materials designed to help increase the power output and reliable lifetime of solar panels and ultimately lower total system costs for PV power. In consumer electronics, DuPont material technologies enable the latest trends in devices, such as high-speed data transfer and thinner size. For semiconductor fabrication and printed circuit board manufacture, the segment offers innovative materials for lower total cost of ownership. This segment offers unique organic light emitting diode (OLED) technology that will enable display manufacturers to deliver superior OLED device performance with lower manufacturing costs. In advanced printing, the segment continues to extend its DuPont™ Cyrel® flexographic printing offering, which enables greater quality, productivity and sustainability for package printing; and, DuPont is expanding its leadership position in pigmented inks for digital printing applications.

Key CapabilitiesPolymer chemistryPhotopolymersFluorochemistryFilms and lamination processPrecision patterningParticle and dispersion scienceApplication developmentInorganic electronic materials

Key Products & ServicesPhotovoltaic materialsCircuit packaging materialsSemiconductor fabrication materialsMaterials for displaysFlexographic printing systemsAdvanced printing materials

Core MarketsAerospace/aircraftAutomotiveConsumer electronicsDisplays Flexographic printing Inkjet printing MilitaryPhotovoltaicsSemiconductor fabrication

Growth Strategies

• Commercialize differentiated products for photovoltaics, consumer electronics, advanced printing and industrial markets

• Invest in capacity for growing markets

• Deep application development capability

• Drive productivity to fund growth


2014 2015 2016Net sales 2,381 2,070 1,960Operating earnings 336 359 358Operating earnings margin 14.1% 17.3% 18.3%Research and development 138 126 115Depreciation and amortization 97 100 87Equity in earnings of affiliates 20 24 31Segment net assets 1,359 1,323 1,186Affiliate net assets 137 139 146Purchases of property, plant and equipment 52 45 51

Operating Earnings

2015

(dol

lars

in m

illio

ns)

2014

$400

$300

$200

$100

$02016

Jon D. KempPresident DuPont Electronics & Communications

2016 Sales Data


Electronic materials 41%

Photovoltaics products 22%

High-performance films 10%

Printing and packaging materials 27%

By Major Industry

Advanced printing 27%

Consumer electronics 31%

Photovoltaics 22%

Other 20%

By Region

Asia Pacific 57%

North America* 22%

Europe** 17%

Latin America 4%


Divestitures and Shutdowns (2014–2016)DuPont Apollo Ltd – shutdown (2014)

DuPont Data Book 14

DuPont Industrial BiosciencesDuPont Industrial Biosciences is a leader in creating world-changing solutions for a more sustainable world. The segment utilizes advanced science and engineering to deliver market-driven innovations that improve performance, boost productivity and reduce environmental footprints for its customers and provide better choices for everyday life. Industry-scale biotechnology, innovation and intellectual property are the core advantages and growth drivers for its bioactive solutions, bio-based materials, and biorefining offerings. Industry-leading enzymes and natural ingredients deliver enhanced value in a wide range of industries. They are used in carbohydrate processing and the production of biofuels from corn and biomass to improve yields and process performance; detergent enzymes permit cold-water washing, which saves energy; and baking enzymes improve the texture and extend the freshness of baked goods. DuPont is the leading provider of micro-ingredients for animal feed that improve the sustainability, safety and efficiency of swine and poultry production. Renewably-sourced biomaterials provide enhanced performance and sustainability for carpeting, apparel, cosmetics and industrial fluids. The Clean Technologies business delivers process design and engineering solutions to help organizations become safer, more efficient and reduce emissions.

Key CapabilitiesBiotechnologyBioprocessing Microbial engineering and production platformsEnzyme design and industrial scale fermentationPolymer scienceAnimal nutrition scienceProcess design and engineering

Key Products & ServicesEnzymesBio-PDO™ propanediolSorona® PTT polymerYeastBetaineDirect-fed microbialsMECS® sulfuric acid technologyBELCO® clean air technologiesSTRATCO® alkylation technologyIsotherming® hydroprocessing

Core MarketsAnimal nutritionDetergentsBiofuels productionFood and beverageCarpet and apparel fiberSulfuric acidOil refiningPhosphate fertilizer

William FeeheryPresident DuPont Industrial Biosciences



Operating EarningsGrowth Strategies

• Expand core enzyme offerings and processing technology

• Drive innovation and increase penetration in high-growth markets

• Execute on capacity release and expansions to support growth plans

• Rapidly commercialize transformative technologies like cellulosic ethanol and biobased polymers

• Continue to drive productivity improvements through operational excellence

• Defend and protect intellectual property2015

(dol

lars

in m

illio

ns)

2014

$300

$250

$200

$150

$100

$50

$02016

2016 Sales Data


Enzymes and related products 68%

Biomaterials 14%

Process technologies 18%

By Major Industry

Food and animal nutrition 29%

Grain processing and biofuels production 21%

Household and personal care 18%

Carpet, apparel and textiles 14%

Acid recovery and refining technologies 18%

By Region

Europe** 26%

North America* 42%

Asia Pacific 26%

Latin America 6%


Acquisitions and Joint Ventures (2014–2016)Industrial Technology business from Dyadic International, Inc. (2015)

DuPont Data Book 15

DuPont Nutrition & HealthDuPont Nutrition & Health is a world leader in the food ingredients industry. We use renewable raw materials to create a wide range of ingredients that food manufacturers use to provide safer, healthier, affordable and more nutritious food for consumers. Our ingredients include probiotics, soy protein, fibers, cultures, antioxidants, antimicrobials, emulsifiers, texturants, enzymes, sweeteners and proprietary blends commercialized as ingredient systems. Our solutions allow food formulations to be healthier, through the reduction of sugar, fat and salt, or by including products that actively promote digestive or immune system health, such as probiotics or soy protein made with patent-pending technology delivering critical value for beverage applications in sports performance, weight management and clinical nutrition. Our solutions provide protection that ensures the food we eat is safer and keeps foods fresher longer, while helping to reduce food waste and carbon emissions. They also allow greater cost efficiency by helping to speed up production processes, reduce waste or optimize outputs.

Key CapabilitiesFood science Health and nutrition scienceMicrobiology and fermentationExtraction and separation technologyApplication know-how

Key Products & ServicesProbiotics Soy protein Fibers Cultures Antioxidants Antimicrobials Emulsifiers Texturants Ingredient systems Sweeteners

Core MarketsFood and beverageDietary supplementsChild nutritionSports nutrition

Matthias Heinzel PresidentDuPont Nutrition & Health

Operating EarningsGrowth Strategies

• Provide value creation in nutrition solutions, affordability, convenience, improved health and food protection

• Advance on our industry-leading food and nutrition science

• Expand position in developing economies with rapid population growth and local food formulations


2014 2015 2016

Net sales 3,529 3,256 3,268Operating earnings 369 373 504Operating earnings margin 10.5% 11.5% 15.4%Research and development 122 113 116Depreciation and amortization 264 236 223Equity in earnings of affiliates — — —Segment net assets 5,942 5,457 5,182Affiliate net assets 7 9 4Purchases of property, plant and equipment 112 120 111

2015

(dol

lars

in m

illio

ns)

2014

$600

$500

$400

$300

$200

$100

$02016

2016 Sales Data


Probiotics/cultures and food protection 19%

Protein solutions 24%

Emulsifiers 17%

Systems and texturants 23%

Functional ingredients and diagnostics 17%

By Major Industry

Bakery 8%

Beverages 11%

Confectionary 8%

Dairy 20%

Dietary supplements 9%

Frozen desserts 5%

Meat 12%

Oils and fats 3%

Other 24%

By Region

Europe** 28%

North America* 36%

Asia Pacific 21%

Latin America 15%


DuPont Data Book 16

DuPont Performance MaterialsDuPont Performance Materials provides its customers with innovative polymer science solutions and expert application development assistance to enhance the performance, reduce the total system cost and optimize the sustainability of their products. Key market segments include transportation, packaging for food and beverages, electrical/electronic components, material handling, healthcare, construction, semiconductor and aerospace. As a percentage of net sales, DuPont Performance Materials is among the most global of the DuPont businesses, with expansion in developing markets. The segment has established itself as the industry leader in high performance renewably-sourced and sustainable polymers with a broad and expanding portfolio of products.

Key CapabilitiesPolymer scienceApplications developmentMaterials processingOperational excellenceGlobal market access

Key Products & ServicesEngineering polymersFlexible packaging resinsIndustrial resinsPerformance elastomers

Core MarketsAutomotivePackagingElectrical/ElectronicsConstructionIndustrialFood serviceConsumer durables

Randy StonePresidentDuPont Performance Materials Operating EarningsGrowth Strategies

• Deliver innovative products and market-focused solutions through world-class application development

• Drive operating discipline and productivity

• Leverage global capabilities and value chain expertise

• Accelerate growth in developing markets

2015

(dol

lars

in m

illio

ns)

2014

$1,400

$1,200

$1,000

$800

$600

$400

$200

02016

2016 Sales Data


Elastomers 3%

Engineered parts 8%

Engineering resins 53%

Ethylene co-polymers 28%

Intermediates 4%

Other 4%

By Major Industry

Transportation 37%

Packaging 12%

Electrical and electronics 16%

Construction 5%

Personal and healthcare 4%

Industrial 15%

Consumer 7%

Other 4%

By Region

Europe** 26%

North America* 31%

Asia Pacific 37%

Latin America 6%


Divestitures and Shutdowns (2014–2016)Glass Laminating Solutions/Vinyls – Sold (2014)SPA Joint Venture – Sold Shares (2014)Neoprene business – Sold (2015)Teijin DuPont Films Japan Limited Joint Venture – Sold Shares (2016)


2014 2015 2016Net sales 6,059 5,305 5,249Operating earnings 1,267 1,216 1,297Operating earnings margin 20.9% 22.9% 24.7%Research and development 99 96 104Depreciation and amortization 139 125 130Equity in earnings (losses) of affiliates (77) (8) 27Segment net assets 3,125 2,918 2,711Affiliate net assets 238 171 146Purchases of property, plant and equipment 134 159 160

DuPont Data Book 17

DuPont Protection SolutionsDuPont Protection Solutions is a global leader in engineered products and systems that protect people, the environment, critical assets and processes, as well as providing sustainable building solutions. The segment satisfies the growing needs of governments, businesses, and consumers globally for solutions that make life safer and healthier. By combining chemistry, material science and engineering with the strength of highly regarded brands such as DuPont™ Kevlar®, Nomex®, Tyvek®, and Corian®, the segment delivers solutions to a large number of markets including industrial, construction, consumer, military and law enforcement, automotive, aircraft, and energy. In addition to serving its existing customer base, DuPont Protection Solutions is investing in the future with growth initiatives such as solutions for healthcare, pharmaceutical and logistics industries.

Key CapabilitiesNovel polymer chemistry and material scienceDeep application development know-howProprietary process technologyGlobal asset and value chain footprintMarquee brands

Key Products & ServicesDuPont™ Kevlar® fiberDuPont™ Nomex® fiber and paperDuPont™ Tyvek® protective material and other selective barriersDuPont™ Tychem® chemical protection suitsDuPont™ Corian® solid surfaces DuPont™ Zodiaq® quartz surfaces

Core MarketsIndustrialConstructionConsumerMilitary and law enforcementAutomotiveAerospace and aircraftOil and Gas/Energy

Rose LeePresidentDuPont Protection Solutions

Growth Strategies

• Accelerate demand creation in non-woven, aramids and surfaces solutions

• Develop breakout growth in selective barriers, high-strength/temperature, decorative and design applications

• Establish leading market positions in new domains in protection solutions

• Strengthen asset reliability enabling superior quality and service

Operating Earnings

2015

(dol

lars

in m

illio

ns)

2014

$700

$600

$500

$400

$300

$200

$100

$02016

2016 Sales Data


Tyvek®/Typar® 37%

Solid surfaces 18%

Aramids products 45%

By Major Industry

Consumer 14%

Military and law enforcement 8%

Automotive 6%

Construction 19%

Industrial 53%

By Region

Europe** 28%

North America* 46%

Asia Pacific 21%

Latin America 5%




Divestitures and Shutdowns (2014–2016)Sontara® – sold (2014)

DuPont Data Book 18

Edward D. Breen Chair of the Board and Chief Executive Officer

Lamberto AndreottiChairman of the Board of Bristol-Myers Squibb Company

Robert A. BrownPresident of Boston University

Alexander M. CutlerFormer Chairman and Chief Executive Officer of Eaton

Eleuthère I. du PontPresident of Longwood Foundation

James L. GalloglyFormer Chairman and Chief Executive Officer of LyondellBasell Industries N.V.

Marillyn A. HewsonChairman, President, and Chief Executive Officer of Lockheed Martin Corporation

Lois D. JuliberFormer Vice Chairman of Colgate-Palmolive Corporation

Ulf M. (“Mark”) SchneiderChief Executive Officer of Nestle S.A.

Lee M. ThomasFormer Chairman and Chief Executive Officer of Rayonier

Patrick J. WardChief Financial Officer of Cummins, Inc.

As of March 2017

Board of Directors DuPont Senior Leadership

Edward D. BreenChair of the Board and Chief Executive Officer

Marc DoyleExecutive Vice President

Richard C. OlsonSenior Vice President Corporate Operations

Nicholas C. FanandakisExecutive Vice President

and Chief Financial Officer

James C. CollinsExecutive Vice President

Stacy L. FoxSenior Vice President and General Counsel

DuPont Legal

Douglas W. MuzykaSenior Vice President and

Chief Science and Technology Officer

Benito Cachinero-SánchezSenior Vice President

DuPont Human Resources

Copyright © 2017 DuPont. The DuPont Oval Logo, DuPont™, and all products denoted with a ™ or ® are trademarks or registered trademarks of E. I. du Pont de Nemours and Company or its affiliates. All rights reserved.

DuPont 974 Centre RoadWilmington, DE 19805dupont.com

http://dupont.com

2016 DUPONT DATA BOOK - s2.q4cdn.com · DuPont Data Book 1 DuPont Investor Relations The DuPont DATA BOOK has been prepared to assist financial analysts, ... (iii) the ability of

Documents